Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

January 2019 Issue of The Medicine Maker

Welcome to the January issue. Upfront explores a collaborative project that aims to cut the cost of gene therapy and the EMA’s revised guidelines to better protect the environment. Minzhang Chen explains why the Chinese pharmaceutical market is already more advanced than many in the West imagine in “In My View,” while our cover feature explores the highs and lows for pharma in 2018. Ioannis Manolopoulos argues that serialization will certainly help in the battle against counterfeiters, but there are other steps that manufacturers can take, in NextGen; while George Chressanthis and Charlie Thompson explain why pharma could be the number one target for politicians in the US. In our latest Sitting Down With… Sir Alasdair Breckenridge considers how Brexit will impact pharma.

Register to download

Register here to download any issue of The Medicine Maker for FREE.

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login as a Guest or via Social Media

Articles featured in this issue

Business & Regulation Trends & Forecasts

The Pharma Playground

| Stephanie Sutton

As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. But what can we do?

Manufacture Advanced Medicine

Continuous Investment

| Stephanie Sutton

How a collaborative project aims to cut the cost of gene therapy

Business & Regulation Standards & Regulation

Proactive Policies

| Maryam Mahdi

Gearing up for 2019, the EMA shares revised guidelines to better protect the environment.

Discovery & Development Drug Discovery

Bon Appetit?

| Maryam Mahdi

Scientists continue to unravel obesity – and seek new drugs to control weight gain.

Manufacture Advanced Medicine

Trials of a Medicine Maker

What lies ahead for Gene and Eva in 2019? Cell and gene therapies!

Business & Regulation Drug Discovery

Here's to New Beginnings

| Stephanie Sutton

Conversations around drug pricing look set to continue for years, but the industry is also experiencing fantastic breakthroughs in science.

Manufacture Supply Chain

Search and Destroy

| Joannis Manolopoulos

Serialization will certainly help in the battle against counterfeiters, but there are other steps that manufacturers can take.

Manufacture Technology and Equipment

Back to Nature

| Bill Whitford

It’s time for pharma to leave behind the highly energy-dependent and inflexible processes of the 20th century. Let’s “biologicalize” manufacturing.

Manufacture Bioprocessing - Upstream & Downstream

Process Intensification: Getting More From Less

| Serena Fries Smith

Intensifying or simplifying your bioprocess can mean more product, shorter manufacturing times, or lower costs.

Business & Regulation Trends & Forecasts

Pharma in the Firing Line

| George Chressanthis, Charlie Thompson

With the US back to divided government, the US pharma industry could be the number one target for politicians.

Business & Regulation Standards & Regulation

A Knight's Tale

| Maryam Mahdi

Sitting Down With… Sir Alasdair Breckenridge; Chairman of the Advisory Board, the Centre of Regulatory Excellence of the Government of Singapore...

Other issues of 2019